Sign In
Free Newsletter
Bausch + Lomb, Walmart partner for in-store eye care clinics
The companies are teaming up to offer free samples and resources as part of “Eye Care for My Care” across 40 U.S. locations during Healthy Vision Month.
Photo of the day: Bausch + Lomb grants $25K to guide dog nonprofit
The eye care company, which has its corporate offices in Bridgewater, is supporting two Seeing Eye puppies, who will be trained to assist people with blindness and low vision.
Bausch + Lomb closes $2.5B XIIDRA acquisition
“We expect to quickly take a leading position in the growing prescription dry eye category with the XIIDRA acquisition and MIEBO launch and, importantly, help the millions of patients not currently receiving adequate treatment for dry eye disease,” Bausch + Lomb Chairman and CEO Brent Saunders said.
Bausch + Lomb acquires Blink for $106.5M
Just days after announcing its plans to buy a prescription treatment from Novartis for $2.5 billion, the eye care company said it purchased the OTC product line from Johnson & Johnson Vision.
Bausch + Lomb to buy dry eye disease treatment for $2.5B
Affecting 35 million Americans alone, the affliction is becoming more prevalent because of the increased use of digital screens, according to the company, which has its corporate offices in Bridgewater.
Bausch + Lomb ‘reshaping’ executive team
“With these changes to the executive management team, our leaders will be closer to customers and patients, which will set the stage for accelerated growth and propel Bausch + Lomb toward a highly competitive, efficient and effective future,” Chairman and CEO Brent Saunders said in a statement.
Two hires to succeed Bausch + Lomb exec
Effective April 24, Bob Bailey will take over as executive vice president and chief legal officer, and Andrew Stewart will lead Ophthalmic Pharmaceuticals.
Former Bausch + Lomb CEO returns to lead company (updated)
Brent Saunders, who was head of the firm from 2010 to 2013, will succeed Joseph Papa, who announced in July 2022 that he would step down.
Rescue dog inspires new Bausch + Lomb line
The Project Watson products are formulated to help support pups eyes, ears and overall wellbeing, according to the company, which has corporate offices in Bridgewater.
Bausch + Lomb CEO to step down
Joseph Papa has already relinquished his role as chairman. He will remain at the head of the company and a member of the board until a new leader is named.
Bausch + Lomb starts trading, misses expectations
The former Bausch Health subsidiary priced its initial public offering of 35 million common shares at $18 per share—below the estimated range of between $21 and $24.
Bausch Health enters separation agreement with subsidiary
As part of the deal, the company expects to transfer all or a portion of the remaining equity interest in Bausch + Lomb following completion of that entity's IPO.
